Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Fennogens Investments S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.35 a.m. EETNotification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Fennogens Investments S.A.  Caverion Corporation has on 28 November 2019 received a notification under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of Caverion Corporation by Fennogens Investments S.A. based in Luxembourg has increased above the thresholds of 5 and 10 per cent on 28 November 2019. According to the notification,

Caverion Corporation - Managers' transactions - Fennogens Investments S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.35 a.m. EETCaverion Corporation - Managers' transactions - Fennogens Investments S.A. Person subject to the notification requirement Name: Fennogens Investments S.A. Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Markus Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20191128184519_4 ___________________

Alligator Bioscience AB appoints Chief Operating Officer

Lund, November 29, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX today announced that the company has appointed Dr Malin Carlsson as Chief Operating Officer. She most recently comes from a position as Vice President, Head of Translational Medicine at Ferring Pharmaceuticals in Copenhagen. In Alligator’s management team, Malin Carlsson will have overall responsibility for the company's clinical projects, with emphasis on the development plans for the candidate drugs mitazalimab (ADC-1013) and ATOR-1015, both of which are planned to start phase II clinical studies in 2020. “I am

Caverion Corporation - Managers' transactions - Structor S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.30 a.m. EETCaverion Corporation - Managers' transactions - Structor S.A. Person subject to the notification requirement Name: Structor S.A. Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Markus Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20191128184533_5 ____________________________________________

Notification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Structor S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.30 a.m. EETNotification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Structor S.A.  Caverion Corporation has on 28 November 2019 received a notification under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding in Caverion Corporation by Structor S.A., a company 100% owned by Fennogens Investments S.A. based in Luxembourg, has decreased below the thresholds of 10 and 5 per cent on 28 November 2019.

Interim Report Third Quarter 2019

FluoGuide A/S ("FluoGuide") today announces its results for the period 01/July/2019 – 30/Sep/2019. The full report is available on the company’s homepage.Morten Albrechtsen, CEO of FluoGuide, comments: “We are very pleased that the supply chain for FG001 has been established to support the first clinical study in humans and the process for FG001 manufacturing was successfully transferred to vendors who can make it to a quality needed for human use. This is good news and a major de-risking for a positive proof-of-concept clinical result in patients with glioblastoma undergoing surgery. Also,

Change of number of shares and votes in Rejlers

As previously announced, Rejlers AB (publ) (“Rejlers”) has carried out a directed issue of 1,600,000 shares of series B to qualified investors at a subscription price of SEK 96.40 per share (for further information, see Rejlers’ press releases on 24 and 25 October 2019). As a result thereof, the number of shares and votes in Rejlers has changed. The number of shares in Rejlers today, the last trading day of the month, amounts to 19,687,909 shares, whereof 1,749,250 shares of series A and 17,938,659 shares of series B. The total number of votes in Rejlers amounts to 35,431,159.

Number of shares and votes in EQT

The number of shares and votes in EQT AB (publ) (“EQT AB”) has changed as a result of the issue of class C shares resolved upon by the board of directors on 13 November 2019 on the basis of an authorization from the annual general meeting on 27 June 2019. The share issue forms part of the EQT Share Program resolved upon by the annual general meeting. EQT AB holds all class C shares. The class C shares will be delivered to qualifying participants in the program and converted into ordinary shares at the end of the holding period in accordance with the terms and conditions of the EQT Share

Reclassification of series B shares in Moberg Pharma AB (publ)

STOCKHOLM, November 29[th], 2019. During November 2019, Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has, in accordance with the conversion clause in the Company’s articles of association, reclassified 660,843 series B shares into the same number of ordinary shares. The reclassification entails an increase in the number of ordinary shares and a decrease in the number of series B shares, but does not affect the total number of shares or votes in the Company.Before the reclassification, the total number of shares in Moberg Pharma amounted to 18,853,510, of which 18,192,667 were

Safeture AB (publ) publishes interim report for third (3) quarter 2019

Summary of interim Report “Parent company” or “Safeture”, comprises of Safeture AB with company number 556776-4674, without subsidiaries. “The Group” comprises the Parent company, including subsidiaries. On September 30, 2019, the Parent company owned 100% of the shares in GWS Production (Singapore) Pte Ltd, 99,99% of the shares in GWS do Brasil Solucões e Sistemas Tecnológicos em Seguranca Ltda and 35% of the shares in Carefindy AB (minority interest). THE GROUP First nine months (2019-01-01 to 2019-09-30) · Net turnover amounted to 16 132 (13 445) TSEK, an increase of 20,0%

Sectra’s six-month interim report 2019/2020: Imaging IT Solutions’ order bookings exceed SEK 2 billion on a rolling 12-month basis

Press release – Linköping, November 29, 2019 – Demand for the international medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) products increased and record-high order bookings were reported for the most recent 12-month period. A significant number of the orders pertain to long-term projects with new customers. In line with what has been previously stated, these projects had a negative impact on cash flow and earnings during the first half of 2019/2020. The projects’ earnings and cash flows will improve as the systems are gradually put into

InCoax Networks AB’s Interim Report, January–September 2019

During the third quarter, additional evaluation studies started and the first reference customers are in place. 26 potential customers are in test phase and commercial discussion are underway. Ongoing work with five major operators is providing exciting opportunities in the short and medium term.Financial performance July–September 2019 · Net sales amounted to SEK 178,947 (408,972), which is equivalent to a decrease of 56% compared with the corresponding period in the preceding year. · The company posted an operating loss of SEK –13,624,785 (–11,347,662), a reduction driven

Date for 2020 AGM and Nomination Committee of Sectra AB

Linköping, Sweden, November 29, 2019 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has decided that the company’s Annual General Meeting (AGM) will be held on September 8, 2020 in Linköping, Sweden. A Nomination Committee has been appointed in accordance with the resolution of the AGM 2019.Sectra has appointed a Nomination Committee comprising four members, one of whom is the Chairman of the Board and three of whom represent the largest shareholders in the company based on the number of votes. The Nomination Committee was

LIQUIDITY PROVIDING AGREEMENT

Faron Pharmaceuticals Oy LIQUIDITY PROVIDING AGREEMENT Appointment of Lago Kapital as Liquidity Provider Company announcement, Turku, 29 November 2019 at 9.01 AM (EET)Inside information TURKU - FINLAND- Faron Pharmaceuticals Oy (AIM: FARN) ("Faron" or the "Company"), the clinical stage biopharmaceutical company, announces that it has entered into a liquidity providing agreement (the "LP Agreement") with Lago Kapital Ltd ("Lago Kapital"). Under the LP Agreement, Lago Kapital will quote bids and offers for the Company's share within the framework for the Nasdaq First North

Interim report for the period 1 January – 30 September 2019

EWPG Holding AB (publ) reports significant progress during the first three quarters of 2019 In Q3, EWPG Holding AB (publ) (the “Company”, “Eco Wave Power” or “EWP”) has been focused on the strengthening of our technology, patent portfolio and expanding our core team and projects pipeline, allowing us to address the global interest for our technology, accelerate the execution of wave energy licensing processes, and strengthen our implementation capacity.Comments to the financials Numbers in parentheses refers to outcomes during the corresponding period of the previous year. Third

GomSpace (provider of nanosatellites) announces its quarterly results for the third quarter 2019

GomSpace Group AB (the “Company”) announces its interim report for the third quarter of 2019. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report:  Third quarter summary 1 July – 30 September 2019 (2018) · Order intake decreased to T.SEK 26,500 (56,469), a decrease of 53% · Net revenues decreased to T.SEK 15,765 (33,608), a decrease of 53% · Gross margin decreased to 11% (34%) · Operating profit (loss) increased to a negative T.SEK 27,270 (a negative 30,357) · Earnings per share were a negative SEK 0.

Increased number of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 58,613,270following a directed share issue of a total of 183,672 shares.Catena Media has, as announced on 14 October 2019 , resolved on a directed share issue of a total of 183,672 shares as payment of the final part of the purchase price for the acquisition of ASAP Italia S.r.l. The share issues have been registered with the Maltese authorities in November 2019. Subsequent to the share issues, the number of shares and votes

Change in the number of shares and votes in AcadeMedia

The number of shares and votes in AcadeMedia AB has during November increased through conversion of subscription warrants relating to the warrants programme for group management implemented at the Extraordinary General Meeting on 1 June 2016 (Warrant program 2016). In total, the number of shares and votes has increased with 84,460 ordinary shares and as many votes. Today, the last trading day of the month, there are in total 105,548,345 shares in AcadeMedia. 105,300,103 shares are ordinary shares with one vote per share and 248,242 shares are C shares with one tenth of a vote per share.

Bravida continues growth in Denmark – acquires Alpedalens VVS A/S

Bravida Danmark A/S has signed an agreement with Hoffmann A/S on the acquisition of Alpedalens VVS in Fredericia, Denmark. Alpedalens VVS has about 35 employees and had a turnover of around 40 MDKK in 2018.Alpedalens VVS, a Danish plumbing and HVAC company, was founded in 1961 and has been a member of the Hoffman group since 2016. Alpedalens VVS specialises in service and installation of everything from district heating and heat pumps to installation solutions for industries and companies.    - I am very pleased to welcome all Alpedalens VVS employees to Bravida. We have cooperated with

Further bond repurchases

Net Gaming Europe AB (publ) has made further repurchases of the Company’s own corporate bonds on the market corresponding to a nominal amount of SEK 30 million.The repurchases are related to the Company’s own bond loan which has an outstanding nominal amount of SEK 375 million. Including the previously communicated repurchases, Net Gaming’s bond repurchases are SEK 67 million. Net Gaming’s bond loan is listed on Nasdaq Stockholm’s Corporate Bond List under the ticker “NETGAM002”. The bond has a variable interest rate of Stibor (3m) +7.25 percent and matures in September 2020. “We

Company Description & information on cash position

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   Faron Pharmaceuticals Oy Publication of Company Description and information on Company's cash position   Company announcement, 29 November 2019 at 9.00 AM (EET)Inside information TURKU - FINLAND -

Concentric receives new order for electric water pumps from global OEM

Concentric AB has been awarded a contract to supply electrically driven and controlled coolant pumps to a global OEM of trucks and buses. The pump will be used for thermal management of the batteries and power electronics on their new range of mid-size electric trucks. This new pump utilises a larger motor than Concentric’s other e -pumps and with a nominal power output of 600W it can deliver a higher flowrate and pressure. Production will start in 2021 and the contract runs until 2025 with total sales estimated to amount to SEK 150 million. In order to strengthen the customer

Interim report June - September 2019

Quant releases the interim report for June - September 2019.June-September · Net sales for the period increased by 4.8% to EUR 47.9 (45.7) million due to the acquisition of Sataservice in August 2018. Organically, net sales decreased by 1.4% · During the quarter three contracts were won, one contract was renewed, three contracts were lost, and two contracts were divested, which on balance affected the contract portfolio negatively. Portfolio run rate annualized net sales at the end of the quarter was EUR 178.4 million, compared to EUR 186.6 million during the second quarter of 2019

Increase of number of shares and votes in Vicore Pharma

Gothenburg, November 29, 2019 – Vicore Pharma Holding AB (publ)’s (“Vicore Pharma”, or the “Company”) registered share capital and number of outstanding shares and votes have increased during the month of November 2019.As previously announced, the Company’s board of directors resolved on November 13, 2019, by virtue of the authorization by the annual general meeting held on May 15, 2019, on a directed share issue of 7,800,000 new shares at a subscription price of SEK 16 per share. Through the share issue, Vicore Pharma received issue proceeds of approximately SEK 125 million before issue

There are no items matching the current filter
There are no more items matching the current filter
Back to top